Unraveling the mechanisms of ubiquitin-specific proteases in hepatocellular carcinoma: A focus on inhibitors.
1/5 보강
Due to heterogeneity and the development of drug resistance, Hepatocellular carcinoma (HCC) patients still benefit minimally from current treatment methods.
APA
Xu Y, Ye J (2025). Unraveling the mechanisms of ubiquitin-specific proteases in hepatocellular carcinoma: A focus on inhibitors.. Bioorganic chemistry, 165, 109049. https://doi.org/10.1016/j.bioorg.2025.109049
MLA
Xu Y, et al.. "Unraveling the mechanisms of ubiquitin-specific proteases in hepatocellular carcinoma: A focus on inhibitors.." Bioorganic chemistry, vol. 165, 2025, pp. 109049.
PMID
41037864 ↗
Abstract 한글 요약
Due to heterogeneity and the development of drug resistance, Hepatocellular carcinoma (HCC) patients still benefit minimally from current treatment methods. In recent years, an increasing number of studies have reported the presence of abnormal ubiquitination modifications in HCC. Therefore, exploring the underlying regulatory mechanisms and developing effective interventions hold the promise of providing new treatment options for HCC patients. This article focuses on the deubiquitinating enzymes (DUB) that play a promoting role in the occurrence and development of HCC, emphasizing their mechanisms of action and related small molecule interventions, with the aim of providing new strategies for the treatment of HCC.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Independent Risk Factors and Nomogram-Based Prediction of Pulmonary Fungal Infection in Lung Cancer Inpatients: A Single-Center Retrospective Study.
- CRISPR-based metabolic screening identifies PLCE1 as a pivotal regulator of oncolytic viral antitumor immunity via tumor immune microenvironment remodeling.
- Design, synthesis of 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole derivatives as potential anticancer agents.
- A Retrospective Comparative Study on the Omission Versus Placement of Chest Drain Following Thoracoscopic Sublobar Resection.
- Budget Impact of Venetoclax for Newly Diagnosed Patients with Acute Myeloid Leukemia Aged ≥ 75 Years or with Comorbidities Precluding Intensive Chemotherapy in the United States.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.